Edition:
United Kingdom

Conmed Corp (CNMD.OQ)

CNMD.OQ on NASDAQ Stock Exchange Global Select Market

68.85USD
18 May 2018
Change (% chg)

$0.36 (+0.53%)
Prev Close
$68.49
Open
$68.80
Day's High
$69.12
Day's Low
$68.48
Volume
72,734
Avg. Vol
67,439
52-wk High
$69.54
52-wk Low
$47.94

Latest Key Developments (Source: Significant Developments)

Conmed Q4 Earnings Per Share $1.65
Wednesday, 31 Jan 2018 

Jan 31 (Reuters) - Conmed Corp ::ORATION ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2017 FINANCIAL RESULTS.SEES FY 2018 ADJUSTED EARNINGS PER SHARE $2.11 TO $2.17.Q4 GAAP EARNINGS PER SHARE $1.65.Q4 EARNINGS PER SHARE VIEW $0.63 -- THOMSON REUTERS I/B/E/S.Q4 ADJUSTED EARNINGS PER SHARE $0.69.Q4 SALES $222.6 MILLION VERSUS I/B/E/S VIEW $211.3 MILLION.EXPECTS FULL-YEAR 2018 CONSTANT CURRENCY SALES GROWTH IN 4.0% TO 5.0% RANGE.  Full Article

Conmed Corp announces retirement of CFO ‍Luke A. Pomilio
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Conmed Corp :Conmed Corp announces retirement of chief financial officer.Conmed Corp - ‍Luke A. Pomilio, executive vice president, finance and chief financial officer, has decided to retire​.Conmed Corp - ‍company has initiated a search for a new CFO​.  Full Article

Conmed Corp reports Q3 adjusted earnings per share $0.42
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Conmed Corp :Conmed Corp announces third quarter 2017 financial results.Q3 adjusted earnings per share $0.42.Q3 sales $190.1 million versus I/B/E/S view $187.1 million.Q3 earnings per share view $0.41 -- Thomson Reuters I/B/E/S.Q3 GAAP earnings per share $0.26.Conmed Corp - ‍expects 2017 constant currency sales growth in range of 2.50% to 3.25%​.Conmed Corp - ‍expects 2017 adjusted diluted net earnings per share in range of $1.85 to $1.90​.Fy2017 earnings per share view $1.87, revenue view $780.4 million -- Thomson Reuters I/B/E/S.  Full Article

MedShape sells ExoShape ACL product line to CONMED Corp
Wednesday, 5 Jul 2017 

July 5 (Reuters) - Conmed Corp :Medshape sells exoshape® acl product line to conmed corporation.Medshape inc says ‍conmed to acquire exoshape® acl fixation system​.  Full Article

Conmed Corp reports Q1 adjusted earnings per share $0.38
Wednesday, 26 Apr 2017 

April 26 (Reuters) - Conmed Corp :Conmed Corporation announces first quarter 2017 financial results.Q1 adjusted earnings per share $0.38.Q1 GAAP loss per share $0.16.Q1 sales $186.6 million.Says continues to expect 2017 constant currency sales growth in range of 1% to 3%.Conmed Corp - continues to expect 2017 constant currency sales growth in range of 1% to 3.Conmed Corp - continues to expect 2017 adjusted diluted net earnings per share in range of $1.85 to $1.95.FY2017 earnings per share view $1.89, revenue view $774.6 million -- Thomson Reuters I/B/E/S.  Full Article

Conmed corporation says jury found Surgiquest liable for $2.2 mln in compensatory damages
Wednesday, 12 Apr 2017 

Conmed Corp : Conmed corporation announces jury verdict in delaware litigation against surgiquest . Jury in United States court for district of Delaware returned verdict finding conmed's subsidiary, surgiquest, liable for $2.2 million in compensatory damages . "this litigation will have no impact on availability of, or conmed's ability to distribute" .Conmed corp - surgiquest, is also liable for an additional $10.0 million in punitive damages.  Full Article

Conmed corporation says jury found Surgiquest liable for $2.2 mln in compensatory damages
Tuesday, 11 Apr 2017 

Conmed Corp : Conmed corporation announces jury verdict in delaware litigation against surgiquest . Jury in United States court for district of Delaware returned verdict finding conmed's subsidiary, surgiquest, liable for $2.2 million in compensatory damages . "this litigation will have no impact on availability of, or conmed's ability to distribute" .Conmed corp - surgiquest, is also liable for an additional $10.0 million in punitive damages.  Full Article

Conmed Q4 adjusted earnings per share $0.54
Wednesday, 1 Feb 2017 

Conmed Corp : Conmed Corporation announces fourth quarter and fiscal year 2016 financial results . Q4 adjusted earnings per share $0.54 . Q4 GAAP earnings per share $0.24 . Q4 earnings per share view $0.56 -- Thomson Reuters I/B/E/S . Q4 sales $204.1 million versus I/B/E/S view $204 million . Expects 2017 constant currency sales growth in range of 1% to 3% . Conmed Corp -Company forecasts adjusted diluted net earnings per share in range of $1.85 to $1.95 in 2017 .FY2017 earnings per share view $1.91, revenue view $784.7 million -- Thomson Reuters I/B/E/S.  Full Article

Bovie medical announces sales partnership with CONMED for PlazXact
Thursday, 19 Jan 2017 

Bovie Medical Corp : Bovie Medical announce sales channel partnership with conmed for plazxact(tm) . Bovie Medical Corp - entered into global sales channel partnership agreement with conmed for its PlazXact ablator .Bovie Medical Corp - PlazXact ablator will be marketed as ultrablator bipolar series effective in March 2017.  Full Article

Conmed Corporation announces Q2 2016 financial results
Wednesday, 27 Jul 2016 

Conmed Corp : Conmed corp sees 2016 adjusted diluted net earnings per share are now expected to be in range of $1.83 to $1.9 . Conmed corporation announces second quarter 2016 financial results . Q2 adjusted earnings per share $0.47 . Q2 gaap earnings per share $0.10 . Q2 sales $193.4 million versus i/b/e/s view $191.5 million . Q2 earnings per share view $0.46 -- Thomson Reuters I/B/E/S . Sees fy 2015 revenue $719 million .Than-Anticipated organic sales growth.  Full Article

BRIEF-Conmed Corporation Q1 GAAP Earnings Per Share $0.37

* CONMED CORPORATION ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS